טוען...
Ranolazine for the Suppression of Ventricular Arrhythmia: A Case Series
BACKGROUND: Premature ventricular complexes (PVCs) and ventricular tachycardia (VT) are associated with persistent symptoms and ventricular dysfunction. Approved medical therapies have undesirable side effects and proarrhythmic liability. Ranolazine is a novel antianginal that preferentially blocks...
שמור ב:
| הוצא לאור ב: | Ann Noninvasive Electrocardiol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931933/ https://ncbi.nlm.nih.gov/pubmed/24533675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12137 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|